Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

929 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of mitral transcatheter edge-to-edge repair in patients with mitral annular calcification: A meta-analysis.
Samimi S, Hatab T, Kharsa C, Bou Chaaya RG, Qamar F, Khan SU, Aoun J, Zaid S, Faza N, Little SH, Atkins MD, Reardon MJ, Kleiman NS, Zoghbi WA, Goel SS. Samimi S, et al. Among authors: atkins md. Cardiovasc Revasc Med. 2024 Oct 30:S1553-8389(24)00707-3. doi: 10.1016/j.carrev.2024.10.014. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 39550307
PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid Cancer.
Shobab L, Al-Souri D, Mathews-Kim L, McCoy M, Kuenstner W, Hubbard GK, Kumari S, Chou J, Lee W, Rosen J, Klubo-Gwiezdzinska J, Atkins M, Wartofsky L, Vasko V, Burman K. Shobab L, et al. Among authors: atkins m. Cancers (Basel). 2024 Oct 28;16(21):3632. doi: 10.3390/cancers16213632. Cancers (Basel). 2024. PMID: 39518072 Free PMC article.
Impact of Residual Transmitral Mean Pressure Gradient on Outcomes After Mitral Transcatheter Edge-to-Edge Repair.
Sammour YM, Bou Chaaya RG, Hatab T, Zaid S, Aoun J, Wessly P, Kharsa C, Zoghbi WA, Nagueh S, Atkins MD, Reardon MJ, Faza N, Little SH, Kleiman NS, Goel SS. Sammour YM, et al. Among authors: atkins md. JACC Adv. 2024 Sep 4;3(10):101227. doi: 10.1016/j.jacadv.2024.101227. eCollection 2024 Oct. JACC Adv. 2024. PMID: 39512541 Free PMC article.
Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma.
Long GV, Larkin J, Schadendorf D, Grob JJ, Lao CD, Márquez-Rodas I, Wagstaff J, Lebbé C, Pigozzo J, Robert C, Ascierto PA, Atkinson V, Postow MA, Atkins MB, Sznol M, Callahan MK, Topalian SL, Sosman JA, Kotapati S, Thakkar PK, Ritchings C, Pe Benito M, Re S, Soleymani S, Hodi FS. Long GV, et al. Among authors: atkins mb. J Clin Oncol. 2024 Nov 6:JCO2400400. doi: 10.1200/JCO.24.00400. Online ahead of print. J Clin Oncol. 2024. PMID: 39504507
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma.
Agarwal N, Brugarolas J, Ghatalia P, George S, Haanen JB, Gurney H, Ravilla R, Van der Veldt A, Beuselinck B, Pokataev I, Suelmann BBM, Tuthill MH, Vaena D, Zagouri F, Wu J, Perini RF, Liu Y, Merchan J, Atkins MB. Agarwal N, et al. Among authors: atkins mb. Ann Oncol. 2024 Sep 2:S0923-7534(24)03918-8. doi: 10.1016/j.annonc.2024.08.2338. Online ahead of print. Ann Oncol. 2024. PMID: 39233312
929 results